Charles River Laboratorie...

AI Score

0

Unlock

178.35
-11.79 (-6.20%)
At close: Jan 14, 2025, 3:59 PM
178.00
-0.20%
After-hours Jan 14, 2025, 04:45 PM EST
undefined%
Bid 169.89
Market Cap 9.12B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 8
PE Ratio (ttm) 22.29
Forward PE n/a
Analyst Hold
Ask 179.52
Volume 1,708,280
Avg. Volume (20D) 674,709
Open 179.87
Previous Close 190.14
Day's Range 175.61 - 185.00
52-Week Range 175.61 - 275.00
Beta undefined

About CRL

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent r...

Sector Healthcare
IPO Date Jun 23, 2000
Employees 20,400
Stock Exchange NYSE
Ticker Symbol CRL

Analyst Forecast

According to 14 analyst ratings, the average rating for CRL stock is "Hold." The 12-month stock price forecast is $210, which is an increase of 17.75% from the latest price.

Buy 21.43%
Hold 64.29%
Sell 14.29%
Stock Forecasts

Next Earnings Release

Charles River Laboratories International Inc. is scheduled to release its earnings on Feb 12, 2025, before market opens.
Analysts project revenue of $985.03M, reflecting a -2.81% YoY shrinking and earnings per share of 2.54, making a 3.25% increase YoY.
5 hours ago · Source
-6.34%
Charles River Laboratories shares are trading lowe... Unlock content with Pro Subscription
2 months ago · Source
+13.53%
Charles River Laboratories shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY24 outlook.